S100B and hepatocellular carcinoma: First, our study only illustrates the difference between patients with HCC and healthy controls with respect to the S100 family; the molecular mechanisms underlying the relationship between the S100 family and HCC were not investigated, and thus additional studies are required to determine the mechanisms involved.